Madrigal Pharmaceuticals, Inc. (MDGL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.06B |
| Enterprise Value | 13.22B |
| P/E Ratio | -67.7 |
| PEG Ratio | -1.22 |
| Price/Sales Ratio | 6.47 |
| Price/Book Ratio | 18.67 |
| Enterprise/Revenue | 6.36 |
| Enterprise/EBITDA | -74.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.11 |
| Operating Margin | -0.11 |
| Return On Assets | -0.11 |
| Return On Equity | -0.27 |
| Revenue | 958.4M |
| Revenue/Share | 48.82 |
| Gross Profit | 902.26M |
| EBITDA | -264.47M |
| Net Income | -288.28M |
| Diluted EPS | -12.85 |
| Total Cash | 960.97M |
| Total Cash/Share | 32.86 |
| Total Debt | 354.22M |
| Total Debt/Equity | 0.56 |
| Current Ratio | 3.05 |
| Book Value Per Share | 21.44 |
| 52-Week Change | -18.11 |
| 52-Week High | 615 |
| 52-Week Low | 353.54 |
| Moving Average 50 Days | 489.63 |
| Moving Average 200 Days | 498.09 |
| Average Volume | 333,953 |
| Shares Outstanding | 23.1M |
| % Held by Institutions | 81.57 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
| Last Split Date | July 25, 2016 |